<DOC>
	<DOCNO>NCT00511836</DOCNO>
	<brief_summary>This study effect VIVITROL® alcohol cue-induced craving associate brain activation pattern alcohol-dependent adult recently complete alcohol detoxification seek treatment alcohol dependence . The study power detect whether VIVITROL attenuate block BOLD signal increase response alcohol-related cue . In double-blind portion , subject receive single administration study drug ( VIVITROL 380 mg placebo ) . Subjects complete double-blind portion could opt continue open-label portion receive 2 additional month treatment VIVITROL 380 mg .</brief_summary>
	<brief_title>ALK21-018 : Effects Medisorb® Naltrexone ( VIVITROL® ) Alcohol Craving Treatment-seeking , Alcohol-dependent Adults</brief_title>
	<detailed_description>The double-blind phase consist 6 visit 5- 6-week period include 2 telephone contact 2 functional magnetic resonance imaging ( fMRI ) scan . The optional open-label extension include 2 visit approximately 1 month apart . Subjects complete phase participate total 8 schedule visit ( include 2 fMRI scan 2 telephone contact ) period 14 week . At screening , eligible , consent subject give Actiwatch®-Score device . They instruct record alcohol crave use device throughout double-blind phase . The Actiwatch program beep every 3 hour ±20 minute , thereby signal subject enter crave desire use alcohol , exact moment , scale 0 10 ( 0 crave 10 extreme crave ) . In addition , subject enter drug and/or alcohol use time occurrence . The Actiwatch utilize open-label portion study .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Primary Current diagnosis alcohol dependence , meet least 3 criterion Diagnostic Statistical Manual Mental Disorders , 4th Ed . ( DSMIV ) Recently complete alcohol detoxification seek treatment alcohol dependence Women childbearing potential must agree use approve method contraception study duration Primary Pregnancy lactation Evidence hepatic failure include : ascites , bilirubin &gt; 10 % upper limit normal ( ULN ) and/or esophageal variceal disease Current dependence ( within past year ) benzodiazepines cocaine , current history opioid dependence accord DSMIV criterion Use opioids and/or methadone within 14 day prior screen visit , likely require opioid therapy study period Previous enrollment VIVITROL clinical trial previous VIVITROL experience Known intolerance and/or hypersensitivity naltrexone , carboxymethylcellulose , polylactidecoglycolide ( PLG ) Parole , probation , pending legal proceeding potential incarceration study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>alcoholism</keyword>
	<keyword>addiction</keyword>
	<keyword>alcohol detoxification</keyword>
</DOC>